Ideas and Forecasts on Stocks — Australia — TradingView

AMP - Aussie Master Piece ^.^^AMP's turnaround is gaining real traction! Shares surged over 20% recently following a strong profit guidance upgrade Profitability is rising, with 1H26 underlying NPAT now expected between $170M-$180M, driven by strong growth in China partnerships and favorable investment income The market is finally rewarding the strategic restructuring efforts led by new CEO Blair Vernon Technicals are supporting this breakout: Stock price has hit $2.02, showing significant bullish momentum Strong Buy signals across moving averages (5, 10, 20, 50, 100, and 200 MA) MACD is showing a clear Buy signal Trading volume has surged as investors gain confidence in the company's path to organic growth The market momentum is shifting in AMP's favor. After a long recovery, the stock is showing it has the fuel to sustain this rally. Targeting further upside as earnings visibility improves. 2026 is shaping up to be a pivotal turnaround year for AMP.

by Momentum_Scout

Potential outside week and bullish potential for BGA Entry conditions: (i) higher share price for ASX:BGA above the level of the potential outside week noted on 17th July (i.e.: above the level of $6.10). Stop loss for the trade would be: (i) below the low of the outside week on 15th July (i.e.: below $5.80), should the trade activate.

$EQR.asx EQ Resources Long Best Tungsten play!$EQR.asx EQ Resources Long Best Tungsten play better than NASDAQ:ALM Almonty. Tungsten Price: Western APT $3,139.5 (+$7 & +0.22%) 🔥🔥 The rise continues!

Potential outside week and bullish potential for MYR Entry conditions: (i) higher share price for ASX:MYR above the level of the potential outside week noted on 11th June (i.e.: above the level of $0.265). Stop loss for the trade would be: (i) below the low of the outside week on 9th June (i.e.: below $0.23), should the trade activate.

Watching for a rebound on YAL I've just done some quick charting on YAL and short term we may see a bit of a rebound. Earnings season is coming and macro environment is a bit on the fence again. If Energy rebounds on the Iran/US tensions and the Strait of Hormuz then we may see money rotate back into the energy sector benefiting YAL. The OBV on the recent move down didn't follow. This indicates the buyers may be stepping in and could lead to a bit of a rally. Keep a watch on this one for now. A lower entry would be preferred if looking to buy and hold, but could be a short term trade opportunity on the long side from what I'm seeing. Not financial advice, just my observations.

Bullish potential detected for NAB Entry conditions: (i) retracement back to potential support area of $38.64 (from the open of 5th June) for ASX:NAB , and (ii) observation of market reaction at this potential support area noted above. Depending on risk tolerance, the stop loss for the trade would be: (i) below the rising 50 day MA (currently $37.78), or (ii) below the recent swing low of 1st July (i.e.: $36.74), or (iii) below the long-term support line of 20th February 2025 (i.e.: $35.81).

Bullish potential detected for RHC Entry conditions: (i) higher share price for ASX:RHC along with swing up of indicators such as DMI/RSI, and (ii) observation of market reaction around the potential support/resistance line of $44.52 from the close of 6th March. Depending on risk tolerance, the stop loss for the trade would be: (i) below the potential support level of $42.14 from the open of 17th April, or (ii) below the rising 15 day EMA (currently $41.84).

Potential outside week and bullish potential for EDV Entry conditions: (i) higher share price for ASX:EDV above the level of the potential outside week noted on 2nd July (i.e.: above the level of $3.43). Stop loss for the trade would be: (i) below the low of the outside week on 1st July (i.e.: below $3.19), should the trade activate.

Potential outside week and bullish potential for DNL Entry conditions: (i) higher share price for ASX:DNL above the level of the potential outside week noted on 5th June (i.e.: above the level of $3.87). Stop loss for the trade would be: (i) below the low of the outside week on 2nd June (i.e.: below $3.61), should the trade activate.

Bullish potential detected for BXB Entry conditions: (i) higher share price for ASX:BXB along with swing up of indicators such as DMI/RSI, and (ii) observation of market reaction around the potential support/resistance line of $19.47 from the open of 18th May. Depending on risk tolerance, the stop loss for the trade would be: (i) below the recent swing low from 16th June ($18.46), or (ii) below the rising 15 day EMA (currently $18.36).

Potential outside week and bearish potential for S32 Entry conditions: (i) lower share price for ASX:S32 below the level of the potential outside week noted on 19th June (i.e.: below the level of $4.10). Stop loss for the trade would be: (i) above the high of the outside week on 15th June (i.e.: above $4.63), should the trade activate.

Potential outside week and bullish potential for RWC Entry conditions: (i) higher share price for ASX:RWC above the level of the potential outside week noted on 25th/26th June (i.e.: above the level of $3.91). Stop loss for the trade would be: (i) below the low of the outside week on 23rd June (i.e.: below $3.46), should the trade activate.

Bullish potential detected for LOV Entry conditions: (i) higher share price for ASX:LOV along with swing up of indicators such as DMI/RSI, and (ii) observation of market reaction around the yearly VWAP (currently $23.43). Depending on risk tolerance, the stop loss for the trade (once activated) would be: (i) below the quarterly VWAP (currently $22.51), or (ii) below the recent swing low from 24th June ($21.84).

Bellevue to below $0.70 G'day, thanks for viewing. So, I published an analysis a few months ago that called for a buy-zone at sub 70c for Bellevue. That didn't quite happen and I didn't end up buying. Sour grapes? No, well I was considering how they weren't very profitable, their value destructive hedge book, and also support, resistance, and Elliot wave corrections. I have found a co-incident target for that level again and will be watching closely. If it gets there, will have to consider more whether to buy or not then as there are other competing businesses that may be more attractive such as; - I need to top up my Northern Star holdings. They have issues, but they are resolvable and I like their huge reserves as well as their near-term growth outlook. I will buy to hold for 15-20 years. - Ramelius. I traded them last year for a 43% profit. Knowing that they would significantly reduce production for a couple of years, I didn't want to be the "bag holder" and own a declining share. Sometime in 2027 there should be a re-energised share price as hurdles are cleared and production ramps up again. Expect to hold until they are merged or acquired (expecting M&A to pick up again). But will happily hold if they stay independent. - Tamboran Resources. I feel they will get into the ASX 300 at the next rebalancing in Sept. That is, of course, pure speculation. But they are no minnow anymore with a AUD1.7B market cap. If I can add them to my Super Portfolio (which I can if they are added to the ASX 300) I will be happy. They had some core acreage re-valued around 1000 - 1500% due to a recent deal with INPEX and more acreage is likely to be re-valued as they drill more and prove resources. They will also commence commercial production within the next few months which will help. A lot of growth to come in my view on their road to 2 billion cubic feet of gas production per day, which is their medium to long term goal. Thanks and good luck everyone

Is IBR ready to pump?When looking at the chart I have a noted a list of things that I am seeing for this stock. The company financials appear to have some catalysts that are looking more positive for their future performance. The setup on the charts has some confluency on the OBV currently, but a couple of the pull back appear to have been defended well by the sellers. The RSI indicates that the momentum may be reversing in the short term, but the OBV is confluent with the price increasing. The price has broken above the previous highs and is currently re-testing and looks to be holding on the support. I'd like to see the OBV gaining over the coming days and a candle close above the recent high; if the RSI can cool off and rebuild back into taking the high again we could see this breakout and bullish market structure confirmed. One to keep your eye on in my opinion.

at support line, returns to resistance around $3 mark Support on long term trend line from early 2025. headwinds around $3. Moves between the two. Right on support line now. Thesis dies if we hit 1.75 area. Should feel good if weekly closes above 2. 15% loss for a 50% gain is the target stop i had in mind. Cap raise was above $3. So expect some manipulation toward there if volume turns up. Gotta get everyone out of their positions .

by curious_bogan

CSL Undervalue Gem That Will Rebound CSL Limited (ASX:CSL) has long been considered one of Australia’s premier healthcare stocks, yet recent trading levels suggest it is undervalued relative to its historical benchmarks. Currently hovering around A$100, CSL is priced well below analyst fair value estimates of A$155, reflecting a discount of roughly 36%. This gap is largely due to FY26 earnings pressure, including US$5 billion in impairments tied to CSL Vifor and restructuring charges that temporarily obscure the strength of its plasma and vaccine businesses. Historically, CSL commanded premium valuation multiples of 28–30x earnings, compared to today’s ~19x. Sector peers average closer to 36x, underscoring the discount. Importantly, CSL’s plasma-derived therapies remain resilient, supported by structural demand drivers such as ageing populations and chronic disease prevalence. The vaccine division also provides defensive earnings streams, though near-term demand fluctuations in the U.S. have weighed on sentiment. The rebound has already begun, with shares climbing 14% from June lows. However, the decisive recovery is expected in FY27, once restructuring charges fade and margins normalize. Key catalysts include successful execution of the CSL Seqirus demerger, stabilization in plasma pricing, and renewed investor rotation into defensive healthcare amid global macro uncertainty. Risks remain: execution missteps in restructuring, prolonged weakness in vaccine demand, or continued capital rotation into growth sectors could delay recovery. Yet, for long-term investors, CSL offers a compelling value play. Its fundamentals—market leadership in plasma therapies, strong R&D pipeline, and defensive healthcare positioning—remain intact. Bottom line: CSL is undervalued today, with the rebound underway but full recovery likely around FY27. Patient investors may find this an attractive entry point into a high-quality healthcare stock poised to regain its premium valuation multiples.

by danny_peanuts

GMG Possible strong up trend or sharp down trend toward the 26 m Key points :  HH HL across 3 time frames ( 1hr – 4hr – daily )  Half cup formation and breakout  WMA 50 – SMA 50 BELOW PRICE  SAM 50 CROSS SMA200 JUST BLEO THE BRAKOUT POINT  No noticeable volume increase I wouldn’t put an entry yes as imbalance have been 99% filled above price But below there are 9% of imbalance zones and open gap not filled which if there is a sharp pull back. it is possible the we can see price go towards the 26.00 marks.

by gtelectricalcontracting

$AWC breaking out Good consolidation period and now making a clear breakout. Significant underperformer compared to $AA .

Nice breakout $SGM #SGM. Consolidation, good washout and retest Good consolidation period for $SGM, good washout and retest. Steel price remains strong. I am hoping for a better than expected result in Feb 2022. I currently hold a long position.

Tyro Payments Targets on chart, 0.820 is key level for this local range, Hold 0.820 and a move into targets looks more probable

by gillman_hugh

Golden Cross Loading?Price has reclaimed every major EMA and continues to print higher highs and higher lows. The 50 EMA is now on the verge of crossing above the 200 EMA while Relative Strength vs SPY continues to improve. With price holding above all key moving averages, the trend appears to be shifting from recovery to expansion. Key observations: • Price above 10, 21, 50 and 200 EMAs • 50 EMA approaching a Golden Cross with the 200 EMA • Relative Strength making new highs • Buyers remain in control while structure stays intact The next phase could come if the Golden Cross confirms and price continues building above the recent breakout zone.

Spring Setup Forming?AVG is starting to look interesting here. It’s still a highly speculative play, but the structure is improving and the chart is showing early signs of a potential move out of the current range. Price broke down from the larger range back in April 2025. Since then, the market has essentially moved sideways with no real trend. Last month we saw a sharp pullback that may have formed a spring on the local range. This spring occurred on much lower volume compared to the Selling Climax (SC), which suggests the market may not require a deep retest of that level. On the weekly chart, price has now pulled back into the local 50% retracement, and volume has been declining during this pullback. That combination often signals that selling pressure is fading and the market may be preparing for the next leg higher. Targets First target: EQ of the range Second target: Range highs if momentum continues Stop‑Loss Initial SL can be placed below the spring low If price breaks upward, the SL can be trailed higher since the broader trend is still technically bearish and we want to protect gains Overall, this remains a speculative setup, but the structure is tightening and the risk‑to‑reward is becoming more favorable if the spring holds and buyers step in.